Back to Search
Start Over
Supplementary Data from Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Revised Supplementary Data Demonstrating All Supplementary Figures 1-6 and Supplementary Table 1
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b392d6003debfc0c061f1af4e291b028